The US Centers for Disease Control and Prevention announced $107 million in emergency funding on June 18 to combat an expanding Ebola outbreak in the Democratic Republic of the Congo and Uganda — as the rare Bundibugyo strain pushed confirmed cases to 875 and deaths to 202, with health officials warning the outbreak could surpass the deadliest Ebola epidemic ever recorded, even as less than 10% of the funding pledged by international donors has actually reached affected communities.
The U.S. Centers for Disease Control and Prevention said on Thursday it would make available $107 million in emergency funding to strengthen its domestic and international response to the Ebola outbreak in the Democratic Republic of Congo and Uganda.
A month after the World Health Organization declared an international emergency, the outbreak of the rare Bundibugyo strain has grown to 875 confirmed cases, including 202 deaths, with warnings mounting that it could become the worst Ebola outbreak on record — surpassing the 2014 to 2016 West Africa epidemic that killed more than 11,000 people.
The warning that this outbreak “could become the worst on record” deserves to be taken at face value. The 2014-16 West Africa epidemic — the largest Ebola outbreak in history, which killed more than 11,000 people across Guinea, Liberia, and Sierra Leone — remains the benchmark against which every subsequent outbreak is measured. That officials are invoking it as a plausible trajectory for the current DRC/Uganda outbreak, rather than as a worst-case hypothetical, signals genuine alarm within the global public health community.
What the $107 Million Funds
In addition to this direct, boots on the ground support provided by CDC experts, CDC recently accessed $107 million in emergency funding from the infectious disease rapid response reserve fund to expand and accelerate these activities to strengthen both international response and domestic readiness.
The agency currently has 23 field staff supporting epidemiological investigations and the DRC health ministry, Dr. Satish Pillai, the incident manager for the CDC’s Ebola response, said in a briefing. There are over 125 CDC staff across the DRC and Uganda working on the response, he said.
“Critically, we’re also working with the government of DRC to support preparedness in provinces immediately west of the outbreak zone to contain the spread of the outbreak,” he said. The teams in Uganda are also helping with border health support, including airport screening assessments, Pillai added.
The geographic emphasis on “provinces immediately west of the outbreak zone” reflects the central strategic challenge of any Ebola response: preventing geographic spread before it accelerates beyond the capacity of existing health infrastructure to contain it. Ituri Province remains the epicentre of transmission in the DRC, with continued spread reported across multiple health zones.
The Strain That Has No Vaccine
Ebola spreads through direct contact with infected bodily fluids and contaminated materials rather than through airborne transmission, making international spread less likely than with diseases such as Covid-19 or measles.
That mode of transmission is the source of whatever relative reassurance exists in this outbreak’s risk assessment — and it is also why the Bundibugyo strain’s lack of an approved vaccine or treatment is so consequential for the people in the affected region. Unlike the Zaire strain of Ebola, for which an effective vaccine (Ervebo) has existed since 2019 and was deployed successfully against subsequent outbreaks, Bundibugyo has no licensed countermeasure.
Today, the Department is announcing that, working with Congress, it intends to provide $50 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to develop medical countermeasures for the Bundibugyo strain of Ebola that is responsible for the current outbreak in the DRC. This funding would support laboratory studies and clinical trials using ethically proven methods, and manufacturing for Bundibugyo medical countermeasure candidates.
That $50 million commitment to CEPI — announced separately from the $107 million CDC funding — represents an acknowledgment that even a fully resourced containment response cannot substitute for the absence of a vaccine. Developing and manufacturing a new vaccine candidate, even on an emergency timeline, takes months to years — time that an active, growing outbreak does not afford.
The Funding Gap That Could Determine the Outcome
Less than 10% of pledges made to support the response in Congo and Uganda have been received from donors, Africa’s top health body said earlier on Thursday. Donors have pledged $910 million, including $80 million from African Union member states, but so far less than $90 million has actually been released for the affected countries, an Africa CDC official said.
This gap — $910 million pledged, less than $90 million actually delivered — is arguably the most consequential number in the entire outbreak response. Pledges made at international donor conferences carry political and diplomatic weight, but they do not buy vaccines, fund treatment centres, or pay health workers. The 10% delivery rate suggests that the international community’s response, measured by what has actually reached the ground rather than what has been promised in press releases, remains dramatically under-resourced relative to the scale of the threat.
The United States says it is the biggest donor to the response and has asked others to contribute.
The US positioning itself as the largest actual donor — while simultaneously calling on other countries and institutions to deliver on pledges already made — is a familiar pattern in international humanitarian response: the gap between what wealthy nations and institutions promise publicly and what they actually disburse has been a recurring feature of crisis response for decades, from the 2014-16 West Africa epidemic itself through to the present outbreak.
The World Cup Connection — and Why It’s Precautionary, Not Alarming
The CDC said it was maintaining regular contact with host cities for the FIFA World Cup 2026, which is being held across the US, Canada, and Mexico, although officials stressed that the current outbreak does not pose an elevated risk to the tournament.
The mention of the World Cup in CDC briefings is a routine feature of outbreak communication protocol rather than a sign of elevated concern. Any infectious disease event during a period of mass international travel and gathering prompts public health agencies to verify, proactively and publicly, that they have assessed the relevant risk pathways. Given Ebola’s bodily-fluid transmission route, the risk of World Cup-related spread is genuinely low — but the CDC’s willingness to address the question directly reflects standard outbreak communication practice during a major global sporting event.
What Happens Next
Two weeks ago, CDC published two MMWRs assessing the risks to the United States and modeling what this outbreak could look like in central Africa over the coming months under a range of scenarios. Those, the model reinforces the trajectory of you’re seeing currently and shows that strong immediate support is needed to help slow or stop the spread of Ebola in DRC and prevent further spread in the region.
The CDC’s own modelling, according to Dr. Pillai, reinforces the current trajectory — meaning that the path the outbreak has been on is consistent with continued, not slowing, transmission. Whether the $107 million in newly released US funding, combined with whatever fraction of the broader $910 million pledge eventually materialises, is sufficient to bend that trajectory downward before case counts climb significantly further is the question that will determine whether this outbreak becomes a contained regional crisis or the next entry in the grim history of Ebola’s deadliest epidemics.
LoudFact.com is an independent global news and explainer platform. This report is based on reporting from Reuters, the CDC Newsroom transcript, GMA News, ITIJ, and the US Embassy in Uganda as of June 18-19, 2026.
